JENNIFER EVANS: Open Payments
NPI 1790335008 · SAINT LOUIS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$314 in 15 payments from 11 companies in 2025. Trend: 2023 $1,156 · 2024 $203 · 2025 $314
Food & beverage: $314
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 2 | $61 |
| Novo Nordisk Inc | 2 | $40 |
| Boston Scientific Corporation | 1 | $39 |
| Abbott Laboratories | 1 | $27 |
| SCPHARMACEUTICALS INC. | 1 | $26 |
| Novartis Pharmaceuticals Corporation | 1 | $24 |
| Biosense Webster, Inc. | 1 | $24 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 3 | $22 |
| E.R. Squibb & Sons, L.L.C. | 1 | $22 |
| AstraZeneca Pharmaceuticals LP | 1 | $15 |
Products named: REPATHA, Wegovy, General - CRM_CRM, JOT DX, FUROSCIX, LEQVIO, LifeVest, CAMZYOS.
Industry payments across MO — which companies pay providers there.
